Navigation Links
Multiple Campylobacter Genomes Sequenced

In 1995, the first complete bacterial genome sequence was published. Now, nearly 200 bacterial genomes have been completed, and a new one hits the scientific press most weeks. This burgeoning industry is not just scientific “stamp collecting,?however. Having all these genome sequences may provide useful clues about why some bacteria cause human disease, how to control their spread, and how to treat the infections caused by them. By comparing genome sequences, scientists can learn much more about what makes a bacteria tick than they can learn from a single sequence.

Derrick Fouts and his colleagues have taken this comparative approach with Campylobacter. Infection with a Campylobacter species is one of the most common causes of human bacterial gastroenteritis. In the US, 15 out of every 100,000 people are diagnosed with campylobacteriosis every year, and with many cases going unreported, up to 0.5% of the general population may unknowingly harbor Campylobacter in their gut annually. Diarrhea, cramps, abdominal pain, and fever develop within 2? days of picking up a pathogenic Campylobacter species, and in most people, the illness lasts for 7?0 days. But the infection can sometimes be fatal, and some individuals develop Guillain-Barré syndrome, in which the nerves that join the spinal cord and brain to the rest of the body are damaged, sometimes permanently.

Campylobacteriosis is usually caused by C. jejuni, a spiral-shaped bacterium normally found in cattle, swine, and birds, where it causes no problems. But the illness can also be caused by C. coli (also found in cattle, swine, and birds), C. upsaliensis (found in cats and dogs), and C. lari (present in seabirds in particular). Disease-causing bacteria generally get into people via contaminated food, often undercooked or poorly handled poultry, although contact with contaminated water, livestock, or household pets can also cause disease.

In 2000, C. jejuni was the first food-borne pathogen to b e completely sequenced, but we still know little about how Campylobacter species cause disease. In their search for clues, Derrick Fouts and coworkers have completely sequenced the genome of C. jejuni strain RM1221 (isolated from a chicken carcass) and compared it with the previously sequenced C. jejuni strain NCTC 11168 and with the unfinished sequences of C. coli strain RM2228 (a multi-drug-resistant chicken isolate), C. lari strain RM2100 (a clinical isolate), and C. upsaliensis strain RM3195 (taken from a patient with Guillain-Barré syndrome).

The researchers describe numerous differences and similarities between these different Campylobacter strains and species. For example, there are major structural differences between the genomes caused by the insertion of new stretches of DNA. Some of these pieces of DNA may carry genes that improve bacterial virulence or fitness, so their presence could help to explain the different biological behaviors of these strains. There are also major variations in the genes responsible for synthesis of molecules that are important for the interaction of Campylobacter with the environment. Such differences could underlie the host specificity of the different species.

Differences between the Campylobacter species in genes that are likely to be involved in aspects of bacterial virulence, such as adherence, motility, and toxin formation, are all detailed by Fouts et al., who also describe a new putative Campylobacter virulence locus. Further work is needed to relate these genomic differences to functional differences, but this detailed comparative genomic analysis provides the core blueprint for this important family of human pathogens. And in doing so, it lays the foundation for the development of new ways to monitor and control Campylobacter in the food chain and in human infection.


'"/>

Source:PLoS Biology


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
3. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
4. OHSU researchers discover potential mechanism to repair brain damage linked to Multiple Sclerosis
5. Multiple genes permit closely related fish species to mix and match their color vision
6. Multiple malaria infection inhibits spread of parasite
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2019)... , ... December 01, 2019 , ... ... and greatest tools, technologies, and techniques to hit the life-science landscape. For more ... innovative products speeding work in laboratories and facilitating biological discovery. This year’s crop ...
(Date:11/27/2019)... ... November 26, 2019 , ... Smile ... Ellyn, IL practice for Invisalign® treatment. Invisalign orthodontics uses a series ... a misaligned bite, also known as malocclusion, present both functional and cosmetic concerns. ...
(Date:11/27/2019)... ... November 27, 2019 , ... ... device, equipped with surface electromyography (sEMG) sensors that measure and display muscle activity ... the specific muscles being targeted for treatment. Both patient and therapist can see ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... Lafayette, Indiana (PRWEB) , ... December 04, 2019 ... ... improved strategy to further enhance dissolution and stabilize amorphous materials. Additionally, their PDF ... and enhance the ability to describe these compositions both in regulatory and patent ...
(Date:11/27/2019)... ... November 25, 2019 , ... Silony Medical, a medical technology ... navigated surgery in the UK. The procedure was performed in the UK’s largest ... Aftab and Dr. Alexander Montgomery. The surgery, which took place on July 22, ...
(Date:11/20/2019)... ... November 20, 2019 , ... Defense and aerospace market intelligence ... generation units from 2019-2028. The value of this production is $728 million in ... worth $569 million. , Reference to 2017 is important, as that was ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... for biopharmaceutical R&D, today announced that Immatics Biotechnologies , a clinical-stage ... Biologics® to streamline their R&D operations related to the discovery and ...
Breaking Biology Technology: